Key facts
- It has raised $18.0M; the latest was Later Stage VC in Sep 2024.
- Notable investors include Khosla Ventures, Exitfund, Edward Scal, Ensemble Innovation Ventures, Frederic Moll — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Fresh (Therapeutic Devices)
- ·The full record, as it builds
Funding rounds
No funding rounds for Fresh (Therapeutic Devices) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Fresh (Therapeutic Devices)
Developer of an oral care device designed to reduce gum diseases and infections. The company's device is a professional flossing system used to deep clean between teeth and below the gumline by positioning water flossing jets paired with minty and tingly power rinse, enabling patients to improve oral health and get fresh breath.
- Sector
- Healthcare
- HQ
- Mountain View, CA, United States
- Founded
- 2017
- Employees
- 27
- Ownership
- Privately Held (backing)
Fresh (Therapeutic Devices) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Fresh (Therapeutic Devices) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Fresh (Therapeutic Devices) in its N-PORT filings yet. We sweep new filings monthly.